LRRC25 Is a Potential Biomarker for Predicting Immunotherapy Response in Patients with Gastric CancerZhensong Yang, Mi Jian|Digestive Diseases and Sciences|2025Cited by 2
PDPN+ cancer-associated fibroblasts correlate with the neoadjuvant immunotherapy response in gastric cancerMi Jian|APL Bioengineering|2025Cited by 1